News >

Coffee May Reduce Colon Cancer Recurrence by Over 40%

Laura Panjwani
Published: Friday, Aug 21, 2015

Charles S. Fuchs, MD

Charles S. Fuchs, MD

Consuming four or more cups of coffee per day may reduce risk of recurrence by 42% and death by 34% in patients with stage III colon cancer, according to a recent study published in the Journal of Clinical Oncology.

The results are based on data from 953 patients with stage III colon cancer who during and 6 months following adjuvant chemotherapy prospectively reported their intake of caffeinated coffee, decaffeinated coffee, and nonherbal tea, as well as 128 other items.

The study found that patients consuming four cups or more of total coffee per day experienced an adjusted hazard ratio for colon cancer recurrence or mortality of 0.58 (95% CI, 0.34-0.99), compared with those who did not drink coffee (P = .002) and patients consuming four cups or more of caffeinated coffee experienced a 52% reduction in cancer recurrence or mortality risk compared with abstainers (HR, 0.48; 95% CI, 0.25-0.91; P = .002).

Increasing caffeine intake also resulted in significant reduction in cancer recurrence or mortality (HR, 0.66; 95% CI, 0.47-0.93; P = .006). Nonherbal tea and decaffeinated coffee were not associated with patient outcomes.

To better understand these results, OncLive spoke with study author Charles S. Fuchs, MD, director of the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute.

OncLive: What prompted this study?

Dr Fuchs: The bigger question is, “Why study diet and lifestyle as it pertains to survival for patients diagnosed with colorectal cancer?” Over years of study, we have identified that diet and lifestyle are clear risk factors for colorectal cancer. Individuals who exercise regularly, maintain a healthy weight, and eat properly have a reduced risk of developing colorectal cancer. I would suggest that colon cancer is the best understood cancer for dietary and lifestyle risk factors.

However, the people who are the most interested in this study are not healthy individuals, but people who were recently diagnosed. Approximately 70% of newly diagnosed patients believe there is a diet, lifestyle, or supplement that will improve their cure rate. The issue is, there have never really been adequate studies looking at the impact of diet and lifestyle changes on that population.

Why was coffee investigated specifically as a potential lifestyle factor that could impact survival?

We were determined to conduct a large, prospective study where we measured diet and lifestyle among people who were being treated for colon cancer close to the time of diagnosis. We then followed them to see what aspects of their diet and lifestyle might improve their cure rate. All of the people we studied were treated as part of clinical trials, as well as had surgery and appropriate adjuvant therapy. We collected data on their diet and lifestyle choices before their cancer recurred. It was collected before the patient knew the ultimate outcome.

We examined a number of factors that reduced risk, and they all seemed to be associated with a reduced risk of getting diabetes. We believe that the factors that put you at higher risk for diabetes may also influence the biology of the body and result in a higher risk of recurrence of colon cancer following treatment.

One factor of interest is coffee. A number of studies show that patients who consume regular coffee drinks have a lower risk of developing diabetes. Because of the relationship between coffee and diabetes, and the relationship between diabetes risk and colon cancer, we wanted to investigate if coffee also reduced the risk of colon cancer recurrence.

What were the results of your investigation?

In a questionnaire that we administered to 1000 patients, we measured their coffee consumption, including caffeinated and decaffeinated, as well as other caffeinated beverages, such as tea. We found that regular coffee drinkers experienced a significant reduction in risk of having their cancer recur or dying of cancer. Our study specifically looked at patients with stage III colon cancer or lymph node-positive colon cancer. There was about a 42% improvement in disease-free survival for people who consumed four or more cups of coffee per day following their treatment of colon cancer.

We did look at caffeinated versus decaffeinated coffee, and it seems that only caffeinated coffee has a benefit. When we looked at caffeine intake from any source—chocolate, or other beverages—we did see that increasing caffeine intake is associated with a superior outcome. Therefore, it appears that caffeine may be the key to the survival benefit, but it requires confirmation.

Is there any understanding of why coffee may reduce recurrence?

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Community Practice Connections™: 2nd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing ApplicationFeb 28, 20192.0
Publication Bottom Border
Border Publication